comparemela.com

Latest Breaking News On - Hedge funds weigh in on actinium pharmaceuticals - Page 1 : comparemela.com

Actinium Pharmaceuticals, Inc (NYSEAMERICAN:ATNM) Receives $25 60 Consensus Target Price from Analysts

Shares of Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) have earned an average rating of “Buy” from the six brokerages that are presently covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1 year target price among brokers that have covered the stock […]

Actinium Pharmaceuticals (ATNM) Buy Rating Reaffirmed at HC Wainwright

HC Wainwright reissued their buy rating on shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Free Report) in a report released on Monday, Benzinga reports. The brokerage currently has a $50.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Actinium Pharmaceuticals’ Q2 2024 earnings at ($0.38) EPS, Q3 2024 earnings at ($0.45) […]

Actinium Pharmaceuticals, Inc (NYSEAMERICAN:ATNM) Given Average Recommendation of Buy by Brokerages

Shares of Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) have received an average rating of “Buy” from the five research firms that are presently covering the stock, Marketbeat reports. Five equities research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokerages that have issued a report on […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.